INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 436m ago
HOUSE PTR36m ago
SEC 13F36m ago
ROBINHOOD CHAIN36m ago
DB
Corporate insider

Durso Jerome Benedict

DirectorCIK 0001698665

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells2 / 0
Max Insider Score44
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
33
DB
Durso Jerome BenedictDirector, President and CEO
ALTAltimmune, Inc.
Open-market purchase
BUY$44K
15.0K sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Altimmune, Inc.Director · Dec 22, 2025
44
DB
Durso Jerome BenedictDirector
ALTAltimmune, Inc.
Open-market purchase
BUY
$52K
12.5K sh
Dec 22, 2025
Dec 22, 2025
traded Dec 22, 2025
+0d
SEC FORM 4

Evidence